MedTrace Logo

Evaluation of PK and Safety of D-0120 and Allopurinol

NCT05360628 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-03-01

No results posted yet for this study

Summary

Evaluation of safety and PK interaction between D-0120 and Alopurinol in healthy adult subjects

Conditions

  • Healthy

Interventions

DRUG

D-0120 in combination with Allopurinol

noted above

Sponsors & Collaborators

  • InventisBio Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-02-10
Completion
2022-07-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05360628 on ClinicalTrials.gov